Cyrill Brunner

机构：Bruker (Switzerland) · ORCID：0000-0002-3276-078X

发表论文 46 篇 · 总被引 449 次 · h-index 9

代表论文

• Leveraging molecular structure and bioactivity with chemical language models for de novo drug design (2023 · Nature Communications · 被引 170)
• When barriers ignore the “rule-of-five” (2016 · Advanced Drug Delivery Reviews · 被引 74)
• A novel FRET peptide assay reveals efficient Helicobacter pylori HtrA inhibition through zinc and copper binding (2020 · Scientific Reports · 被引 34)
• De Novo Fragment Design for Drug Discovery and Chemical Biology (2015 · Angewandte Chemie International Edition · 被引 34)
• Discovery of a small molecule ligand of FRS2 that inhibits invasion and tumor growth (2022 · Cellular Oncology · 被引 22)
• High-mass MALDI-MS unravels ligand-mediated G protein–coupling selectivity to GPCRs (2021 · Proceedings of the National Academy of Sciences · 被引 22)